You Are On:
EQUITY
Equity Analysis
  Price
    Gainers & Losers
    Out & Under Performers
    Only Buyers & Sellers
     Advances & Declines
     New Highs & Lows
     Weightage
     5 Day's Up & Down
  Volume
  Analysis
News Analysis
Corporate Info
Corporate Action
Other Market
Financial Ratios    
Panacea Biotec Ltd.
 
BSE Code 531349
ISIN Demat INE922B01023
Book Value 53.97
NSE Code PANACEABIO
Dividend Yield(%) 0.00
Market Cap(Million) 8817.04
P/E(X) 0.00
EPS(Rs.) -2.41
Face Value(Rs.) 1  
Particulars Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Operational & Financial Ratios          
   Earnings Per Share (Rs)-14.29  -15.28  -2.35  -24.99  4.34  
   CEPS(Rs)-10.29  -10.96  1.98  -20.54  13.11  
   DPS(Rs)0.00  0.00  0.00  0.00  0.00  
   Book NAV/Share(Rs)53.17  67.77  82.97  140.53  68.32  
   Tax Rate(%)-39.51  0.00  -12.15  -12.58  28.53  
Margin Ratios          
   Core EBITDA Margin(%)-24.21  -30.75  0.14  1.96  -33.01  
   EBIT Margin(%)-20.36  -36.62  -1.53  2.20  31.93  
   Pre Tax Margin(%)-24.25  -39.60  -3.69  -26.57  8.37  
   PAT Margin (%)-33.84  -39.60  -4.14  -29.92  5.98  
   Cash Profit Margin (%)-24.37  -28.41  3.49  -24.58  18.07  
Performance Ratios          
   ROA(%)-9.57  -9.88  -1.27  -10.56  1.56  
   ROE(%)-23.64  -20.27  -2.11  -23.93  6.59  
   ROCE(%)-11.36  -16.14  -0.70  1.09  11.51  
   Asset Turnover(x)0.28  0.25  0.31  0.35  0.26  
   Sales/Fixed Asset(x)0.30  0.28  0.41  0.52  0.34  
   Working Capital/Sales(x)-5.00  50.58  5.99  1.14  -89.21  
Efficiency Ratios          
   Fixed Capital/Sales(x)3.32  3.58  2.43  1.91  2.96  
   Receivable days25.11  45.26  27.77  15.29  68.81  
   Inventory Days173.06  167.03  97.64  50.55  78.73  
   Payable days306.74  437.99  269.16  258.86  324.70  
Valuation Parameters          
   PER(x)0.00  0.00  0.00  0.00  45.69  
   PCE(x)-10.53  -13.52  89.37  -5.33  15.12  
   Price/Book(x)2.04  2.19  2.14  0.78  2.90  
   Yield(%)0.00  0.00  0.00  0.00  0.00  
   EV/Net Sales(x)2.81  4.03  3.09  1.38  4.27  
   EV/Core EBITDA(x)-25.64  -15.80  50.04  12.55  -13.68  
   EV/EBIT(x)-13.72  -10.97  -199.19  60.07  13.36  
   EV/CE(x)0.81  1.02  1.10  0.52  1.19  
   M Cap / Sales2.58  3.86  3.16  1.37  2.73  
Growth Ratio          
   Net Sales Growth(%)9.16  -31.45  -29.84  10.25  -22.64  
   Core EBITDA Growth(%)53.09  -383.02  -60.64  138.96  -239.83  
   EBIT Growth(%)39.11  -1521.99  -147.32  -92.05  237.69  
   PAT Growth(%)6.45  -549.25  90.58  -676.10  136.97  
   EPS Growth(%)6.45  -549.25  90.58  -676.09  136.97  
Financial Stability Ratios          
   Total Debt/Equity(x)0.31  0.20  0.13  0.08  1.65  
   Current Ratio(x)0.79  1.02  1.29  3.67  0.99  
   Quick Ratio(x)0.33  0.49  0.85  3.08  0.95  
   Interest Cover(x)-5.24  -12.29  -0.71  0.08  1.36  
   Total Debt/Mcap(x)0.15  0.09  0.06  0.10  0.57